DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
MINUTES OF MEETING 1 
March 1-2, 1993 
The Recombinant DNA Advisory Committee (RAC) was convened for its fifty-third 
meeting at 9:00 a.m. on March 1, 1993, at the National Institutes of Health, Building 31, 
Conference Room 6, 9000 Rockville Pike, Bethesda, Maryland 20892. Dr. LeRoy B. 
Walters (Chair) presided. In accordance with Public Law 92-463, the meeting was open 
to the public. The following were present for all or part of the meeting: 
Committee members: 
Constance E. Brinckerhoff, Dartmouth Medical School 
Nancy L. Buc, Weil, Gotshal, and Manges 
Ira H. Carmen, University of Illinois 
Gary A Chase, Johns Hopkins University 
Patricia A. DeLeon, University of Delaware 
Krishna R. Dronamraju, Foundation for Genetic Research 
E. Peter Geiduschek, University of California, San Diego 
Mariann Grossman, University of Michigan Medical Center 
Robert Haselkorn, University of Chicago 
Susan S. Hirano, University of Wisconsin 
Donald J. Krogstad, Tulane University School of Medicine 
Brigid G. Leventhal, Johns Hopkins Hospital 
Abbey S. Meyers, National Organization for Rare Disorders 
A Dusty Miller, Fred Hutchinson Cancer Research Center 
Arno G. Motulsky, University of Washington Medical School 
Robertson Parkman, Childrens Hospital of Los Angeles 
Leonard E. Post, Parke-Davis Pharmaceutical Division 
Marian G. Secundy, Howard University College of Medicine 
Brian R. Smith, Yale University School of Medicine 
Stephen E. Straus, National Institutes of Health 
LeRoy B. Walters, Kennedy Institute of Ethics, Georgetown University 
Doris T. Zallen, VA Polytechnic Institute & State University 
1 The RAC is advisory to the National Institutes of Health (NIH), and its 
recommendations should not be considered as final or accepted. The Office of 
Recombinant DNA Activities should be consulted for NIH policy on specific issues. 
I 
/ 
Recombinant DNA Research, Volume 17 
[59] 
